Canada Authorizes Janssen's COVID-19 Vaccine

Health Canada officials held a technical briefing on COVID-19 vaccines in Ottawa, ON. During this meeting, Health Canada announced the approval of Johnson & Johnson's Janssen COVID-19 vaccine for use in Canada.

Additionally, Canada ordered 10 million doses with options for up to 28 million more. The expected arrival of the Janssen COVID-19 vaccine order is by the end of September 2021.

The Janssen COVID-19 (Ad26.COV2-S) single-shot experimental vaccine leverages Janssen's AdVac and PER.C6® technologies. Janssen’s AdVac® vectors are based on a specific type of adenovirus, which has been genetically modified so that it can no longer replicate in humans and cause disease. Adenoviruses are a group of viruses that can cause the common cold.

This vaccine is authorized in the USA and South Africa.